Acute natriuretic effect of fasidotrilat, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in rats with heart failure

Pharmacology

Volumn 56, Issue 6, 1998, Pages 291-296

  Marie, Christine ^a   Mossiat, Claude ^a   Lecomte, Jeanne Marie ^b   Bralet, Jean ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Laboratoire Bioprojet   (France)

Author keywords

Angiotensin I converting enzyme; Fasidotrilat; Heart failure; Neutral endopeptidase; Renal function

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALINASE INHIBITOR; FASIDOTRILAT; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIURESIS; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NATRIURESIS; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; URINE VOLUME;

ALANINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DIURESIS; ENZYME INHIBITORS; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; LIGATION; MALE; MYOCARDIAL INFARCTION; NATRIURESIS; NEPRILYSIN; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR;

EID: 0031804430     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028212     Document Type: Article

References (37)

1. Schwanz JC, Gros C, Lecomte JM, Bralet J: Minireview. Enkephalinase (EC 3.4.24.11) inhibitors: Protection of ANF against inactivation and potential therapeutic applications. Life Sci 1990;47:1279-1297.
2. Bates ER, Shenker Y, Grekin RJ: The relationship between plasma levels of immunoreactive natriuretic hormone and hemodynamic function in man. Circulation 1986;73: 1155-1161.
3. de Zeeuw D, Janssen WMT, de Jong PE: Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney Int 1992;41:1115-1133.
4. Winaver J, Huffman A, Burnett JC, Haramati A: Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol 1988;254: R776-R784.
5. Abassi Z, Haramati A, Huffman A, Burnett JC, Winaver J: Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol 1990;259:R84-R89.
6. Abassi ZA, Kelly G, Golomb E, Klein H, Keiser HR: Losartan improves the natriuretic response to ANF in rats with high-output heart failure. J Pharmacol Exp Ther 1994; 268:224-230.
7. Lee RW, Raya TE, Michael U, Foster S, Meeks T, Goldman S: Captopril and ANP: Changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure. J Pharmacol Exp Ther 1991;260:349-354.
8. Villareal D, Freeman RH, Johnson RA: Captopril enhances renal responsiveness to ANF in dogs with heart failure. Am J Physiol 1992; 262:R509-R516.
9. Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers W: Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11. and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. J Pharmacol Exp Ther 1993;266:872-883.
10. Trippodo NC, Fox M, Natarajan V, Panchal BC, Dorso CR, Asaad MM: Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure. J Pharmacol Exp Ther 1993; 267:108-116.
11. Gonzalez W, Beslot F, Laboulandine I. Fournié-Zaluski MC, Roques BP, Michel JB: Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with myocardial infarction. J Pharmacol Exp Ther 1996;278:573-581.
12. Gros C, Noel N, Souque A, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Lecomte JM, Bralet J: Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): Rational design, properties and potential cardiovascular applications of glycopril and alatriopril. Proc Natl Acad Sci USA 1991;88:4210-4214.
13. Selye H, Bajusz E, Grasso S, Mendell P: Simple technique for the surgical occlusion of coronary vessels in the rat. Angiology 1960;11:398-407.
14. Pfeffer JM, Pfeffer MA, Braunwald E: Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985;57:84-95.
15. Bralet J, Marie C, Mossiat C. Lecomte JM, Gros C, Schwartz JC: Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. J Pharmacol Exp Ther 1994;270:8-14.
16. Marie C, Mossiat C, Lecomte JM, Schwartz JC, Bralet J: Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction. J Pharmacol Exp Ther 1995;275:1324-1331.
17. Tomoda F, Lew RA, Smith AI, Madden AC, Evans RG: Role of bradykinin in the renal effects of inhibition of angiotensin converting enzyme and endopeptidase 24. 11 and 24. 15 in conscious rabbits. Br J Pharmacol 1996;119:365-373.
18. Pham I, Gonzalez W, El Amrani K, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB: Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol Exp Ther 1993;265:1339-1347.
19. French JF, Anderson BA, Downs TR, Dage RC: Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension. J Cardiovasc Pharmacol 1995;26:107-113.
20. Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB: Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats. J Pharmacol Exp Ther 1995;272:343-351.
21. Kon V, Fogo A, Ichikawa I: Bradykinin causes selective efferent arteriolar dilation during angiotensin 1 converting enzyme inhibition. Kidney Int 1993;44:545-550.
22. Bouaziz H, Joulin Y, Safar M, Benetos A: Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition. Br J Pharmacol 1994;113:717-722.
23. Deck CC, Gaballa MA, Raya TE: Relative contribution of angiotensin II, bradykinin, and prostaglandins to the renal effects of converting enzyme inhibition in rats after chronic myocardial infarction. J Cardiovasc Pharmacol 1996;28:167-174.
24. Bralet J, Mossiat C, Gros C, Schwartz JC: Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins. J Pharmacol Exp Ther 1991;258:807-811.
25. Ura N, Shimamoto K, Kuroda S, Nomura N, Iwata M, Aoyama T, Iimura O: The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats. Clin Exp Hypertens 1994;16:799-808.
26. Mendez RE, Dunn BR, Troy JL, Brenner BM: Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat. Circ Res 1986;59:605-611.
27. Di Nicolantonio R, Morgan TO: Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide. Clin Exp Hypertens [A] 1987;9:19-32.
28. Hansell P, Ulfendahl HR: Effects of atrial natriuretic peptide (ANP) during converting enzyme inhibition. Acta Physiol Scand 1987;130:393-399.
29. Wang SL, Gilmore JP: Renal responses to atrial natriuretic factor during converting enzyme inhibition. Can J Physiol Pharmacol 1985; 63:220-223.
30. Chamienia AL, Johns EJ: The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat. Br J Pharmacol 1991;103: 1893-1898.
31. Wilkins MR, Lewis HM, West MJ, Kendall MJ, Lote CJ: Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives. J Hum Hypertens 1987;1:47-51.
32. Gaillard CA, Koomans HA, Dorhout Mees EJ: Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension 1988; 11:160-165.
33. Gaillard CA, Koomans HA, Rabelink TJ, Boer P, Dorhout Mees EJ: Opposite effects of enalapril and nitrendipine on natriuretic response to atrial natriuretic factor. Hypertension 1989;13:173-180.
34. Wambach G, Schmittenhelm U, Stimpel M, Bönner G, Kaufmann W: Natriuretic action of ANP is blunted by ACE inhibition in humans. J Cardiovasc Pharmacol 1989;13:748-753.
35. Motwani JO, Lang CC, Cramb G, Struthers AD: Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men. Hypertension 1995;25:637-642.
36. Fournié-Zaluski MC, Gonzalez W, Turcaud S, Pham I, Roques BP, Michel JB: Dual inhbition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: A potential therapeutic approach in hypertension. Proc Natl Acad Sci USA 1994; 91:4072-4076.
37. Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR: In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting inhibitors. J Cardiovasc Pharmacol 1996;28:672-678.